Causes of False Positive Results for Stool Occult Blood Tests

Dietary Factors

• Recent consumption of red meat is strongly associated with false positive results in guaiac-based fecal occult blood tests due to the pseudoperoxidase activity of animal hemoglobin 1, 2
• Poultry, fish, and some raw vegetables may also contribute to false positive results 3
• Manufacturers recommend avoiding these foods for 3 days before testing to reduce false positivity rates 1

Medication-Related Causes

• Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen should be avoided for 7 days prior to testing 1, 2
• Aspirin at doses higher than one adult aspirin per day can increase false positive rates 1, 2
• Iron supplements can interfere with test results and should be avoided during the testing period 4

Procedural and Sample Collection Issues

• Digital rectal examination immediately before collecting stool samples can cause trauma-related bleeding, leading to false positive results 4
• Single-stool sample FOBT collected after digital rectal exam in the office has very poor sensitivity and higher risk of false positives 4
• Rehydration of gFOBT slides substantially increases the false positive rate and is not recommended 1, 2

Other Factors

• Laboratory variation in test interpretation can affect results - ongoing technician training and standardized laboratory procedures are important 1

Clinical Implications

• False positive results lead to unnecessary colonoscopies, increasing patient discomfort, costs, and risks 5
• Proper patient education about dietary restrictions and medication avoidance is essential to minimize false positive results 1, 2

Reducing False Positive Results

• Use fecal immunochemical tests (FIT) instead of guaiac-based tests when possible, as they do not require dietary restrictions and have fewer false positives 3, 6
• Ensure proper collection of stool samples from three consecutive bowel movements rather than a single sample 1, 2
• Process guaiac-based tests in clinical laboratories rather than physician offices to improve standardization and reduce interpretation errors 1

Fecal Occult Blood Test Validity

Test Sensitivity and Specificity

• The sensitivity of a single guaiac-based fecal occult blood test (gFOBT) for colorectal cancer is low, ranging from 12.9-13% 7, 8
• The American Cancer Society recommends that gFOBT should be used as a 3-proben test at home, with a sensitivity of 37.1% for non-rehydrated Hemoccult II and 64.3% for Hemoccult SENSA 7
• The specificity of gFOBT is high for low-sensitivity tests (97.7-98.1% for Hemoccult II) but lower for high-sensitivity tests (86.7-87.5% for Hemoccult SENSA) 7

Common Problems with Test Application

• A single stool test after rectal examination in the office has an unacceptably low sensitivity of 4.9% for advanced neoplasia and 9% for cancer 7, 8
• Despite this, 31.2% of physicians reported using only this inadequate method, and an additional 41.2% used both office and home testing methods 7, 9
• This practice leads to false reassurance of patients and wasted resources 8

Correct Test Application

• For guaiac-based tests (gFOBT), the test must be performed correctly with 3 stool samples from consecutive bowel movements at home 10
• Patients should avoid certain medications, such as NSAIDs and aspirin, for 7 days before the test, unless taken for heart protection 10
• Dietary restrictions, including avoidance of vitamin C and red meat, should be followed for 3 days before the test 10
• A positive test should be followed by a colonoscopy, not a repeat stool test 10
• A negative test requires annual repetition 10
• The American Cancer Society recommends annual testing with either gFOBT or immunological tests (FIT), with follow-up colonoscopy for positive results 7, 10

Stool Occult Blood Testing for Colorectal Cancer Detection

Introduction to Stool Occult Blood Testing

• The American Gastroenterological Association recommends a 3-day stool occult blood testing protocol with 2 samples from each stool to maximize cancer detection while maintaining acceptable specificity, as single-sample testing has poor sensitivity of only 4.9% for advanced disease, whereas the 3-day protocol detects up to 92% of cancers with repeated annual testing 11
• The 3-day collection period increases the likelihood of detecting intermittent bleeding from colorectal neoplasms, which do not bleed continuously, as colorectal cancers and adenomas bleed sporadically, so sampling multiple stools over consecutive days captures bleeding that might be missed with a single sample 11

Mortality Benefit of Proper 3-Day Testing

• Annual screening with properly performed 3-day FOBT reduces colorectal cancer mortality by 15-33%, as yearly testing with the 3-day protocol reduced colorectal cancer deaths by 33% after 13 years, while biennial testing reduced deaths by 15-21% 11
• The mortality benefit of proper 3-day testing depends entirely on using the proper 3-day collection protocol with appropriate dietary restrictions and follow-up colonoscopy for positive results, as any positive test on any of the 6 specimens requires colonoscopy and never repeat the FOBT 11

Fecal Occult Blood Testing for Colorectal Cancer Screening

Primary Testing Options

• The American Cancer Society recommends ordering a fecal immunochemical test (FIT) or high-sensitivity guaiac-based fecal occult blood test (gFOBT) with proper 3-day home collection from consecutive bowel movements for colorectal cancer screening 12, 13, 14, 15
• FIT reacts specifically to human globin, eliminating dietary interference, and requires annual testing with collection of specimens from consecutive bowel movements 12, 15
• gFOBT detects blood through pseudoperoxidase activity of heme or hemoglobin and has proven mortality reduction of 15-33% from randomized controlled trials 12, 15

Critical Testing Requirements

• Proper collection protocol requires collecting 2 samples from each of 3 consecutive bowel movements at home, as test sensitivity improves with each additional stool sample 12, 13, 14, 15
• Collection of all 3 samples is essential because test sensitivity improves with each additional stool sample 12, 15

Follow-Up Based on Results

• Any positive result requires colonoscopy within 60 days to examine the entire colon, as recommended by the American Cancer Society 12, 13

Important Clinical Context

• These tests primarily detect cancer rather than small adenomatous polyps, which do not tend to bleed, and bleeding from cancers or large polyps may be intermittent, making multiple consecutive samples essential 12, 13, 14
• The tests are specific to lower GI sources, with guaiac-based tests also detecting upper GI bleeding 12, 13, 15

Evidence‑Based Guidelines for Fecal Occult Blood Testing (FOBT)

Test Performance and Sample Collection

• Large adenomatous polyps (≥ 1–2 cm) can cause intermittent gastrointestinal bleeding, whereas smaller polyps rarely bleed; this intermittency may lead to missed detection on individual stool samples, highlighting the need for proper multi‑day collection protocols. 16
• Intermittent bleeding from colorectal cancers or large polyps may not be captured in every stool specimen; therefore, a three‑day stool collection (two samples per bowel movement) is recommended to maximize test sensitivity. 16
• The recommended collection protocol for guaiac‑based FOBT is two specimens from each of three consecutive bowel movements performed at home, which improves sensitivity with each additional sample. 16

FIT‑Specific Considerations

• Fecal immunochemical tests (FIT) do not require dietary restrictions because they specifically detect human hemoglobin globin, eliminating interference from red meat, vegetables, or vitamin C. 17
• High‑quality prospective studies show that aspirin, NSAIDs, warfarin, or clopidogrel use does not adversely affect FIT performance; consequently, anticoagulant or antiplatelet therapy need not be altered before FIT testing. 17

Interpretation of Positive Results and Follow‑Up

• Any positive FOBT result—whether from a guaiac‑based test or FIT—mandates a diagnostic colonoscopy to examine the entire colon; repeat FOBT is not an appropriate follow‑up strategy. [16][17]
• Colonoscopy should be scheduled promptly, ideally within 60 days of a positive FOBT result, to reduce the risk of disease progression. [16][17]

Digital Rectal Examination–Based Fecal Occult Blood Testing Is Not Recommended for Colorectal Cancer Screening

Test Performance of DRE‑Based FOBT

Guideline Recommendations Against DRE‑Based FOBT

Management of a Positive FOBT Result

Common Clinical Pitfalls

Proper FOBT Collection Protocol (Home‑Based)

Dietary and Medication Considerations for FOBT